Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 60

1.

Network vs. Pairwise Meta-Analyses: A Case Study of the Impact of an Evidence-Synthesis Paradigm on Value of Information Outcomes.

Zafari Z, Thorlund K, FitzGerald JM, Marra CA, Sadatsafavi M.

Pharmacoeconomics. 2014 Jun 12. [Epub ahead of print]

PMID:
24920194
[PubMed - as supplied by publisher]
2.

Incorporating external evidence in trial-based cost-effectiveness analyses: the use of resampling methods.

Sadatsafavi M, Marra C, Aaron S, Bryan S.

Trials. 2014 Jun 3;15:201. doi: 10.1186/1745-6215-15-201.

PMID:
24888356
[PubMed - in process]
Free PMC Article
3.

Economic and health effect of full adherence to controller therapy in adults with uncontrolled asthma: A simulation study.

Zafari Z, Lynd LD, FitzGerald JM, Sadatsafavi M.

J Allergy Clin Immunol. 2014 May 26. pii: S0091-6749(14)00570-3. doi: 10.1016/j.jaci.2014.04.009. [Epub ahead of print]

PMID:
24875619
[PubMed - as supplied by publisher]
4.

The effect of weekly text-message communication on treatment completion among patients with latent tuberculosis infection: study protocol for a randomised controlled trial (WelTel LTBI).

van der Kop ML, Memetovic J, Patel A, Marra F, Sadatsafavi M, Hajek J, Smillie K, Thabane L, Taylor D, Johnston J, Lester RT.

BMJ Open. 2014 Apr 9;4(4):e004362. doi: 10.1136/bmjopen-2013-004362.

PMID:
24719431
[PubMed]
Free PMC Article
5.

The importance of measuring asthma control in emerging economies.

FitzGerald JM, Sadatsafavi M.

Int J Tuberc Lung Dis. 2014 Mar;18(3):254. doi: 10.5588/ijtld.14.0096. No abstract available.

PMID:
24670557
[PubMed - in process]
6.

The impact of incorporating Bayesian network meta-analysis in cost-effectiveness analysis - a case study of pharmacotherapies for moderate to severe COPD.

Thorlund K, Zafari Z, Druyts E, Mills EJ, Sadatsafavi M.

Cost Eff Resour Alloc. 2014 Mar 13;12(1):8. doi: 10.1186/1478-7547-12-8.

PMID:
24625208
[PubMed]
Free PMC Article
7.

Heterogeneity's ruses: the neglected role of between-individual variability in longitudinal studies of COPD exacerbations.

Sadatsafavi M, Fitzgerald JM.

Thorax. 2014 Feb 18. doi: 10.1136/thoraxjnl-2013-205061. [Epub ahead of print]

PMID:
24550058
[PubMed - as supplied by publisher]
Free Article
8.

Post-hospital syndrome in adults with asthma: a case-crossover study.

Sadatsafavi M, Lynd LD, Fitzgerald JM.

Allergy Asthma Clin Immunol. 2013 Dec 23;9(1):49. doi: 10.1186/1710-1492-9-49.

PMID:
24364886
[PubMed]
Free PMC Article
9.

The preventable burden of productivity loss due to suboptimal asthma control: a population-based study.

Sadatsafavi M, Rousseau R, Chen W, Zhang W, Lynd L, FitzGerald JM; Economic Burden of Asthma Study Team.

Chest. 2014 Apr;145(4):787-93.

PMID:
24337140
[PubMed - indexed for MEDLINE]
10.

Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study.

Sadatsafavi M, Lynd LD, Marra CA, FitzGerald JM.

Thorax. 2014 Apr;69(4):328-34. doi: 10.1136/thoraxjnl-2013-203998. Epub 2013 Nov 26.

PMID:
24281327
[PubMed - indexed for MEDLINE]
11.

Complementary and alternative asthma treatments and their association with asthma control: a population-based study.

Chen W, Fitzgerald JM, Rousseau R, Lynd LD, Tan WC, Sadatsafavi M.

BMJ Open. 2013 Sep 4;3(9):e003360. doi: 10.1136/bmjopen-2013-003360.

PMID:
24005131
[PubMed]
Free PMC Article
12.

Comparative outcomes of leukotriene receptor antagonists and long-acting β-agonists as add-on therapy in asthmatic patients: a population-based study.

Sadatsafavi M, Lynd L, Marra C, Bedouch P, Fitzgerald M.

J Allergy Clin Immunol. 2013 Jul;132(1):63-9. doi: 10.1016/j.jaci.2013.02.007. Epub 2013 Mar 29.

PMID:
23545274
[PubMed - indexed for MEDLINE]
13.

Need for speed: an efficient algorithm for calculation of single-parameter expected value of partial perfect information.

Sadatsafavi M, Bansback N, Zafari Z, Najafzadeh M, Marra C.

Value Health. 2013 Mar-Apr;16(2):438-48. doi: 10.1016/j.jval.2012.10.018. Epub 2013 Jan 26.

PMID:
23538197
[PubMed - indexed for MEDLINE]
14.

Costs and health outcomes associated with primary vs secondary care after an asthma-related hospitalization: a population-based study.

Sadatsafavi M, FitzGerald M, Marra C, Lynd L.

Chest. 2013 Aug;144(2):428-35. doi: 10.1378/chest.12-2773.

PMID:
23519289
[PubMed - indexed for MEDLINE]
15.

Associations of ambient air pollution with chronic obstructive pulmonary disease hospitalization and mortality.

Gan WQ, FitzGerald JM, Carlsten C, Sadatsafavi M, Brauer M.

Am J Respir Crit Care Med. 2013 Apr 1;187(7):721-7. doi: 10.1164/rccm.201211-2004OC.

PMID:
23392442
[PubMed - indexed for MEDLINE]
16.

A quantitative benefit-risk analysis of isoniazid for treatment of latent tuberculosis infection using incremental benefit framework.

Sadatsafavi M, Marra C, Marra F, Moran O, FitzGerald JM, Lynd L.

Value Health. 2013 Jan-Feb;16(1):66-75. doi: 10.1016/j.jval.2012.09.006.

PMID:
23337217
[PubMed - indexed for MEDLINE]
17.

Trends in asthma-related direct medical costs from 2002 to 2007 in British Columbia, Canada: a population based-cohort study.

Bedouch P, Marra CA, FitzGerald JM, Lynd LD, Sadatsafavi M.

PLoS One. 2012;7(12):e50949. doi: 10.1371/journal.pone.0050949. Epub 2012 Dec 5.

PMID:
23227222
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Future impact of various interventions on the burden of COPD in Canada: a dynamic population model.

Najafzadeh M, Marra CA, Lynd LD, Sadatsafavi M, FitzGerald JM, McManus B, Sin D.

PLoS One. 2012;7(10):e46746. doi: 10.1371/journal.pone.0046746. Epub 2012 Oct 11.

PMID:
23071626
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Two-level resampling as a novel method for the calculation of the expected value of sample information in economic trials.

Sadatsafavi M, Marra C, Bryan S.

Health Econ. 2013 Jul;22(7):877-82. doi: 10.1002/hec.2869. Epub 2012 Aug 30.

PMID:
22933363
[PubMed - indexed for MEDLINE]
20.

The "Lost NNT" can be used to represent uncertainty surrounding number needed to treat.

Sadatsafavi M, Ganjizadeh S, Hatala R, Marra C, FitzGerald M.

J Clin Epidemiol. 2012 Aug;65(8):863-8. doi: 10.1016/j.jclinepi.2012.01.022. Epub 2012 May 30.

PMID:
22652350
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk